NASDAQ: AMEDAmedisys Revenue
Amedisys revenue was $2.35B for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $598.1M, up 1.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, AMED annual revenue was $2.3B, with 5% growth year-over-year.
AMED past revenue growth
How has AMED's revenue growth performed historically?
Company
5.01%
Industry
8.06%
Market
20.87%
AMED's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
AMED's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
AMED's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
AMED revenue history
Current Revenue
$2.3B
Current Earnings
$43.2M
Current Profit Margin
1.8%
AMED's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance
Be the first to know when AMED announces revenue.
AMED Revenue History By Year
| AMED Yearly Revenue | AMED Revenue | AMED Change | AMED Revenue Growth |
|---|---|---|---|
| 2024-12-31 | $2.35B | $111.94M | +5.01% |
| 2023-12-31 | $2.24B | $13.18M | +0.59% |
| 2022-12-31 | $2.22B | $9.09M | +0.41% |
| 2021-12-31 | $2.21B | $142.59M | +6.88% |
| 2020-12-31 | $2.07B | $115.89M | +5.93% |
| 2019-12-31 | $1.96B | $293.06M | +17.63% |
| 2018-12-31 | $1.66B | $151.31M | +10.01% |
| 2017-12-31 | $1.51B | $92.01M | +6.48% |
| 2016-12-31 | $1.42B | $138.72M | +10.83% |
| 2015-12-31 | $1.28B | $75.99M | +6.31% |
| 2014-12-31 | $1.20B | -$44.79M | -3.59% |
| 2013-12-31 | $1.25B | -$191.49M | -13.29% |
| 2012-12-31 | $1.44B | $22.37M | +1.58% |
| 2011-12-31 | $1.42B | -$182.61M | -11.41% |
| 2010-12-31 | $1.60B | $116.69M | +7.86% |
| 2009-12-31 | $1.48B | $296.96M | +25.01% |
| 2008-12-31 | $1.19B | $489.48M | +70.13% |
| 2007-12-31 | $697.93M | $156.79M | +28.97% |
| 2006-12-31 | $541.15M | $159.59M | +41.83% |
| 2005-12-31 | $381.56M | $154.47M | +68.02% |
| 2004-12-31 | $227.09M | $84.62M | +59.39% |
| 2003-12-31 | $142.47M | $13.05M | +10.08% |
| 2002-12-31 | $129.42M | $19.25M | +17.47% |
| 2001-12-31 | $110.17M | $22.02M | +24.98% |
| 2000-12-31 | $88.16M | -$9.26M | -9.50% |
| 1999-12-31 | $97.41M | $71.95M | +282.51% |
| 1998-12-31 | $25.47M | -$344.00k | -1.33% |
| 1997-12-31 | $25.81M | -$7.71M | -23.01% |
| 1996-12-31 | $33.52M | -$4.07M | -10.82% |
| 1995-12-31 | $37.59M | $8.69M | +30.06% |
| 1994-12-31 | $28.90M | N/A | N/A |
Amedisys Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.